DGAP-News: Aareal Bank AG / Key word(s): Acquisition Aareal Bank Group acquires Westdeutsche ImmobilienBank AG (news with additional features) 22.02.2015 / 13:20 --------------------------------------------------------------------- Aareal Bank Group acquires Westdeutsche ImmobilienBank AG - Preliminary purchase price amounts to EUR 350 million - The acquisition will have a distinctly positive effect on earnings, thanks to negative goodwill of approx. EUR 150 million - long-term RoE target of around 12 per cent before taxes remains unchanged - Aareal Bank further strengthens its market position in commercial property financing on strategically important core markets - CEO Dr Wolf Schumacher: "We have exploited an attractive opportunity to execute a value-creating transaction" Wiesbaden, 22 February 2015 - Aareal Bank Group acquires all of the shares of Westdeutsche ImmobilienBank AG (WestImmo), which specialises in commercial property financing. A corresponding sale and purchase agreement was signed today with the previous owner Erste Abwicklungsanstalt (EAA). The purchase price amounts to EUR 350 million, subject to contractually agreed adjustments until the closing date. According to current planning, the transaction - which is subject to the approval of the respective authorities - is expected to be completed during the first half of 2015. Following the acquisition of COREALCREDIT BANK AG in the spring of 2014, Aareal Bank has once again effected a targeted investment in its core Structured Property Financing business by acquiring WestImmo, expanding its strong position on key target markets. Having already spun off non-strategic assets, and following the divestiture of all participations and further balance-sheet items (as agreed with the seller), WestImmo is now a Pfandbrief issuer with a clear focus on its core business. WestImmo's high-quality, low-risk commercial property financing portfolio, which is broadly diversified - both geographically and in terms of the type of financed properties - supplements Aareal Bank's activities in line with the Bank's strategy. Based on a pro-forma extrapolation as at 31 March 2015, WestImmo has total assets of EUR 8.1 billion. The volume of commercial property financings amounts to EUR 4.3 billion, with around one-third in Germany, approx. 38 per cent in Western Europe, and around 9 per cent in North America. The remainder of the portfolio is related to selected other markets. Due to conditions imposed by the EU Commission in connection with the government-funded stabilisation of its former parent entity WestLB (now trading as "Portigon"), WestImmo had to cease originating new business in 2012 and has no longer been active on the market, except for renewals of existing exposures. Despite this restriction and the resulting reduction in business activities, WestImmo is profitable and has a fully functional international banking platform. Its staff have significant expertise in the international property financing business. WestImmo has a solid capitalisation and funding base. Funding liabilities vis-à -vis the current owner will be repaid, all financial guarantees covering parts of WestImmo's portfolio returned and further assets transferred, upon acquisition by Aareal Bank. Furthermore, Aareal Bank will provide a liquidity facility to WestImmo. Aareal Bank aims to integrate WestImmo into the Group as swiftly as possible. Nonetheless, the intention is to retain a significant number of jobs at WestImmo, at least over the medium term. Dr Wolf Schumacher, Chairman of the Management Board of Aareal Bank AG, said: "We have exploited an attractive opportunity - in line with our strategic objectives - to execute a value-creating transaction. At the same time, the fact that we have made a second acquisition - financed from the Bank's own funds - within a period of just over one year is renewed evidence of Aareal Bank Group's strength, and its ability to take strategic action in a rapidly-changing market and competitive environment." Transaction creates value from the outset According to the agreement entered into today, Aareal Bank Group is acquiring WestImmo at a price reflecting a discount compared to WestImmo's equity in accordance with IFRSs. This leads to negative goodwill which will amount to approx. EUR 150 million on a preliminary basis. Aareal Bank will be able to realise this negative goodwill, as a one-off profit, on the closing date. On top of this non-recurring effect, WestImmo - which is operating profitably - will provide a positive contribution to Aareal Bank Group's consolidated operating profit, and is expected to generate a cumulative contribution to earnings per share (EPS) of more than EUR 3.00 over the next three years. Aareal Bank affirms its medium-term target return on equity (RoE) before taxes of approximately 12 per cent, even taking effects of the transaction into account. After completion of the transaction, Aareal Bank will also continue to significantly exceed the various regulatory requirements concerning equity and liquidity, as well as its own medium-term target of 10.75 per cent for its Common Equity Tier 1 ratio. "With the agreed acquisition of WestImmo, we are employing excess capital to create value in the interests of our shareholders. At the same time, we adhere to our dividend policy, strengthening our potential for distributions in the future", Hermann J. Merkens, Aareal Bank's CFO, added. Contact: Aareal Bank AG Corporate Communications Sven Korndörffer Tel.: +49 611 348 2306 sven.korndoerffer@aareal-bank.com Christian Feldbrügge Tel.: +49 611 348 2280 christian.feldbruegge@aareal-bank.com Heinrich Frömsdorf Tel.: +49 611 348 2061 heinrich.froemsdorf@aareal-bank.com Alessandro Schwarz Tel.: +49 611 348 2923 alessandro.schwarz@aareal-bank.com ------------------------------------ Aareal Bank AG, Registered Office: Wiesbaden Commercial Register: Amtsgericht Wiesbaden HRB 13184 Chairman of the Supervisory Board: Marija G. Korsch Management Board: Dr. Wolf Schumacher (Chairman), Hermann J. Merkens (Deputy Chairman), Dagmar Knopek, Thomas Ortmanns +++++ Additional features: Document: http://n.equitystory.com/c/fncls.ssp?u=VOJXJPJLFK Document title: 20150222_Press Release --------------------------------------------------------------------- 22.02.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Aareal Bank AG Paulinenstr.15 65189 Wiesbaden Germany Phone: +49 (0)611 348 - 0 Fax: +49 (0)611 348 - 2332 E-mail: aareal@aareal-bank.com Internet: www.aareal-bank.com ISIN: DE0005408116 WKN: 540811 Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart; Stockholm End of News DGAP News-Service --------------------------------------------------------------------- 325745 22.02.2015
DGAP-News: Aareal Bank Group acquires Westdeutsche
Top 10 Most Recent News Articles
Portillo's Faces Class Action: Investor Losses at Stake
Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...
Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations
ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...
Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit
A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...
Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle
IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...
Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market
A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...
Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market
Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...
Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments
Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....
Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?
A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...
Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough
Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...
Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue ReadingTop 5 Most Recently Viewed Articles
Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa
Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...
Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV
Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...
Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial
Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...
Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future
Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...
Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley
B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...
Continue Reading